Vero
U.S. ICD-10-CM · FY 2027

E88.14 ICD-10-CM Code: HIV-associated lipodystrophy

A clear reference for the official code description, hierarchy, and related coding information from the FY 2027 U.S. release.

Code definition

Official description

E88.14

HIV-associated lipodystrophy

ICD-10-CM diagnosis code · United States clinical modification

Classification

Where E88.14 sits

  1. 1

    Chapter 4

    Endocrine, nutritional and metabolic diseases (E00-E89)

  2. 2

    Section

    Metabolic disorders (E70-E88)

  3. 3

    Category E88

    Other and unspecified metabolic disorders

  4. 4

    Subcategory E88.1

    Lipodystrophy, not elsewhere classified

  5. 5

    Code E88.14

    HIV-associated lipodystrophy

Documentation details

Notes for this code

Inclusion terms

No inclusion terms are listed for E88.14.

Code first

  • any human immunodeficiency virus [HIV] disease (B20)

Use additional code

  • code for adverse effect, if applicable, to identify drug (T37.5X5-)

Excludes1

Conditions that should not be reported together with this code.

No Excludes1 note is listed for E88.14.

Excludes2

Conditions not included here that may be reported separately when present.

No Excludes2 note is listed for E88.14.

Transparency

Source and release

Data release

U.S. ICD-10-CM · FY 2027

Effective date

Oct 1, 2026

Publisher

Vero Scribe Inc.

This reference is generated from Vero’s ICD-10-CM description, hierarchy, and code-note dataset. The visible content and structured data share that source.

Review the CDC/NCHS ICD-10-CM source

Code-specific guidance

Frequently asked questions

What does ICD-10-CM code E88.14 mean?

E88.14 is the FY 2027 U.S. ICD-10-CM code for “HIV-associated lipodystrophy.”

Is E88.14 a billable or specific ICD-10-CM code?

Yes. In the FY 2027 reference data used on this page, E88.14 has no child codes and is presented as a billable/specific code. Always confirm the active code set and payer requirements before use.

Where is E88.14 located in ICD-10-CM?

E88.14 is listed in Chapter 4, Endocrine, nutritional and metabolic diseases (E00-E89), within Metabolic disorders (E70-E88) (E70–E88), under category E88, Other and unspecified metabolic disorders and subcategory E88.1, Lipodystrophy, not elsewhere classified.

What coding notes are listed for E88.14?

No inclusion terms are listed for E88.14 in this reference record. Code-first instructions: any human immunodeficiency virus [HIV] disease (B20). Additional-code instructions: code for adverse effect, if applicable, to identify drug (T37.5X5-). No Excludes1 note is listed. No Excludes2 note is listed.

Keep exploring

Related E88.1 codes

E88.10

Lipodystrophy, unspecified

E88.11

Partial lipodystrophy

E88.12

Generalized lipodystrophy

Ready to transform your clinical documentation?

Join Vero and see how effortless documentation can be.

Try for free

  • No credit card required

  • Cancel anytime